Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity ... (ially make available up to a further $3....)

HOME >> BIOLOGY >> TECHNOLOGY

Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment

Date:4/1/2008

ially make available up to a further $3.4 million to cornerstone a future product or corporate acquisition.

Dr. Ken Macleod, Principal at Paul Capital Healthcare, said: "As with all of our transactions, we conducted rigorous due diligence on both the clinical and commercial potential of Plethora's male health portfolio. We believe that the products within this portfolio are very well positioned to address the needs of men with sexual dysfunction, a condition that affects 20-30 percent of men at some point during their lifetime. Given this large market, Plethora's male health products are an attractive investment opportunity for our fund."

Dr. Steven Powell, Plethora CEO, commented: "This agreement provides us with financial resources to help fulfil our ambitions for the growth of Plethora. Additionally, this investment by a Paul Capital Healthcare fund is a strong vote of confidence in the commercial prospects of our male health franchise. In a climate where equity based financing would be highly dilutive to shareholders, this non-dilutive finance facility will strengthen our balance sheet and help conclude on-going licensing discussions with regard to PSD502. We also expect that this transaction will maximise value realisation from our male health portfolio, including our Timm Medical operation. Also, along with the increased commitment from ETV Capital S.A., this transaction will facilitate the execution of Plethora's product and corporate development ambitions."

For further information contact:

Plethora Solutions Tel : 020 3077 5400

Steven Powell

Plethora City/Financial Enquiries Tel: 020 7379 5151

Maitland

Brian Hudspith/Liz Morley

Paul Capital Healthcare

Lazar Partners:

Fern Lazar Tel: 1 212 867 1762

Email: flazar@lazarpartners.com

Stephanie S
'/>"/>

SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
2. Pharmasset Receives $10 Million of Working Capital
3. Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
4. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
5. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
6. National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
7. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
8. AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
9. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
10. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference

Post Your Comments:

(Date:5/19/2013)... Boston, MA (PRWEB) May 19, 2013 ... providing social media training online, has proudly announced that ... for small business has surpassed 175,000 views on YouTube. ... free social media and SEO tips and training for ... see my students find the YouTube tips helpful for ...

(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...

(Date:5/17/2013)... Organ transplant rejection occurs when the transplant recipient,s immune ... attacks it. It was previously thought that T cells, ... activated by molecules known as chemokines in order to ... the Journal of Clinical Investigation , Fadi Lakkis ... to demonstrate that chemokine stimulation of T cells is ...

(Date:5/17/2013)... May 17, 2013 - Elsevier, a world-leading provider of ... announced the publication of a recent study in ... human blastocysts showing that those with an abnormal chromosomal ... they have developed to blastocysts, thereby classifying the risk ... study the same group has undertaken a retrospective study, ...

Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2 Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2 Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3 Breakthrough for IVF? 2 Breakthrough for IVF? 3

[0] YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group [0] Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group [0] Researchers identify signals that direct the immune system to reject a transplanted organ [0] Breakthrough for IVF?

... ... Spectrum Chemicals & Laboratory Products ... and decapper that will increase productivity and lessen injuries due ... advanced ergonomic design and is engineered to improve throughput in ...

... 10 deCODE genetics,(Nasdaq: DCGN ) today announced ... 2009. A conference call to discuss these results and,recent ... tomorrow,Tuesday, August 11, at 8:00am Eastern Daylight Time/12 noon ... The financial results presented below reflect deCODE,s strategic ...

... MONTREAL, Aug. 10 Enobia Pharma, an emerging biotech ... today announced that it raised US$50 million from its current ... used primarily to fund the ongoing development program for ENB-0040, ... and potentially deadly genetic bone disorder for which there is ...

Spectrum Announces New Distribution of AC-Powered Tool for Crimping and Decapping of Laboratory Vials - The CRIMPenstein™deCODE genetics Announces Second Quarter 2009 Financial Results Enobia Raises US$50M from Current Investors in Series C Financing

(Date:5/20/2013)... Boulder, Colo., USA New Geology ... 16 May 2013 cover a wide swath of ... tectonics, oceanography, geophysics, and paleobotany. Locations studied include ... mine at Alpi Apuane, Italy; Ukraine; Mars; and ... , 1. Rubies, jadeite, and plate tectonics;, ...

(Date:5/19/2013)... bacteria that can grow using hydrogen gas as its ... source of carbon. Researchers at the University of ... Meeting of the American Society for Microbiology. , "This ... hydrogen," says Amit Kumar, a researcher on the study ... Lovley Lab Group at the university. , Under the ...

(Date:5/18/2013)... MD (May 19, 2013) The AGA Research Foundation ... and Damian Augustyn Award in Digestive Cancer, which will ... of Medicine at the University of Pennsylvania, Philadelphia, as ... in pancreas development, regeneration and cancer progression. , "The ... in honor of two distinguished clinicians and AGA Legacy ...

[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] Bacteria use hydrogen, carbon dioxide to produce electricity [0] AGA Research Foundation grant furthers digestive cancer research

... , Registration is now open for the Ecological Society ... in Portland, Oregon. The meeting is expected to draw more ... share emerging research. Jane Lubchenco, an Oregon State marine ... will open the six day meeting with a keynote address ...

... Combined, complimentary therapies have the ability to maximize ... spinal cord repair in rat models, according to a ... who published in a recent issue of Cell Transplantation ... "When transplanted, neural stem cells have demonstrated their ...

... April 17, 2012 /PRNewswire-iReach/ -- Global Information ... showing strong growth in the medical devices markets, driven ... Renal Dialysis Equipment Market to 2017 ... increasingly large elderly population are driving rapid growth in ...

Cached Biology News:Registration open for the Ecological Society of America's 2012 Annual Meeting in Portland, Ore. 2 Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies 2 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 2 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 3 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 4

Registration open for the Ecological Society of America's 2012 Annual Meeting in Portland, Ore.Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows

... Safe Deposit Service ECACC is able to accept ... cGMP for cryo-storage. The cell lines must be ... been produced in accordance with the requirements of ... freedom from mycoplasma, bacteria or fungi. What are ...

Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....

... of expertise in the field of Enzyme-Linked ... most powerful systems on the market. Freedom ... in-microplate tests requiring incubation and washing steps. ... (such as worktable shaker incubators, reader,washer), all ...

... Choice Microsphere/Microarray Stabilizer is a is a ... This product is an aqueous solution ... buffer (phosphate buffered saline), pH 6.6 - ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ...

Biology Products:

cGMP Safe Deposit Facility from European Collection of Cell Cultures (ECACC)Standard and Modified Oligonucleotides Service from Yorkshire Bioscience Ltd ELISA Biopharma from Tecan StabilGuard Choice Microsphere/Microarray Stabilizer from SurModics, Inc.